Switch to:
Synageva BioPharma Corp (NAS:GEVA)
Other Current Liabilities
$0.97 Mil (As of Mar. 2015)

Synageva BioPharma Corp's other current liabilities for the quarter that ended in Mar. 2015 was $0.97 Mil.

Synageva BioPharma Corp's quarterly other current liabilities increased from Sep. 2014 ($0.66 Mil) to Dec. 2014 ($0.91 Mil) and increased from Dec. 2014 ($0.91 Mil) to Mar. 2015 ($0.97 Mil).

Synageva BioPharma Corp's annual other current liabilities increased from Dec. 2012 ($0.00 Mil) to Dec. 2013 ($0.14 Mil) and increased from Dec. 2013 ($0.14 Mil) to Dec. 2014 ($0.91 Mil).


The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Related Terms

Total Current Liabilities

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data

Other Current Liab. 0.000.00-

Synageva BioPharma Corp Quarterly Data

Other Current Liab. 0.00-
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership